SCHEMBL7809574

SCHEMBL7809574

CCOC(=O)c1n[nH]c2cc(OC)c(OC)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.59
ALDH1A1 P00352 3/20 0.58
HPGD P15428 2/20 0.58
GAA P10253 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
GABRA1 P14867 3/20 0.55
GABRA5 P31644 3/20 0.55
GABRA3 P34903 3/20 0.55
GABRA2 P47869 3/20 0.55
GABRA6 Q16445 3/20 0.55
GABRG2 P18507 1/20 0.55
GABRB3 P28472 1/20 0.55
POLB P06746 1/20 0.51
NTRK1 P04629 1/20 0.50
NTRK2 Q16620 1/20 0.50
LMNA P02545 3/20 0.49
TUBB4A P04350 2/20 0.49
TUBB P07437 2/20 0.49
TUBA3C P0DPH7 2/20 0.49
TUBA1B P68363 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1579253 0.91 KDM4E (0.52) KDM4EALDH1A1HPGDGAANPSR1
SCHEMBL492550 0.81 KDM4E (0.64) KDM4EALDH1A1HPGDNPSR1GABRA1
SCHEMBL493081 0.81 KDM4E (0.64) KDM4EALDH1A1HPGDNPSR1GABRA1
SCHEMBL31507475 0.81 KDM4E (0.64) KDM4EALDH1A1HPGDNPSR1GABRA1
SCHEMBL27363663 0.80 PRKAA1 (0.57) KDM4EALDH1A1HPGDGAANPSR1
SCHEMBL12479871 0.80 KDM4E (0.44) KDM4EALDH1A1HPGDGAANPSR1
SCHEMBL20895120 0.79 KDM4E (0.66) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL10569944 0.78 KDM4E (0.58) KDM4EALDH1A1HPGDGAANPSR1
SCHEMBL12090413 0.78 KDM4E (0.69) KDM4EALDH1A1HPGDGAAPOLB
SCHEMBL5479829 0.77 PDE10A (0.52) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792879-B1 Process for preparing 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate DAIICHI SEIYAKU CO (JP) 2001-02-28 EP disclosed
US-5948913-A A CRYSTAL OF 3-(2-(4-(3-CHLORO-2-METHYLPHENYL)-1-PIPERAZINYL)ETHYL)-5,6-DIM ETHOXY-1-(4-IMIDAZOLYLMETHYL)-1H-INDAZOLE DIHYDROCHLORIDE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1999-09-07 US disclosed
US-5837706-A CALMODULIN INHIBITOR FOR SUPPRESSION OF OF NEURONAL CELL DEATH DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-17 US disclosed
EP-0624584-B1 Piperazine derivatives useful as calmodulin inhibitors DAIICHI SEIYAKU CO (JP) 1998-08-19 EP disclosed
US-5681954-A HAS CALMODULIN INHIBITORY ACTIVITY; USEFUL IN TREATING DISEASES OF THE CIRCULATORY ORGANS OR IN CEREBRAL REGION DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-10-28 US disclosed
EP-0792879-A1 HYDRATE FOR MEDICINAL USE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-09-03 EP disclosed
US-5661150-A Drug for neuroprotection DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-08-26 US disclosed
EP-0627219-A1 Use of calmodulin inhibitors for neuroprotection DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1994-12-07 EP disclosed
EP-0624584-A1 Piperazine derivatives useful as calmodolin inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1994-11-17 EP disclosed